$124.37 -1.61 (%) Alexion Pharmaceuticals Inc - NASDAQ

Sep. 28, 2016 | 09:50 AM

Partner Headlines

  1. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily | Aug. 1, 2016 | 15:15PM EST
  2. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 12:13PM EST
  3. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 10:30AM EST
  4. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  5. Schroer: Biotech Will Turn Around

    Benzinga | Feb. 13, 2016 | 22:12PM EST
  6. Baron Funds Comments on Alexion Pharmaceuticals

    GuruFocus | Feb. 8, 2016 | 11:24AM EST
  7. Leerink Is Back On Board The Biotech Train

    Benzinga | Feb. 5, 2016 | 10:32AM EST
  8. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  9. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  10. Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals

    GuruFocus | Jan. 3, 2016 | 22:43PM EST
  11. Big Cap 20 Stocks Setting Up In Bases

    IBD | Dec. 21, 2015 | 18:31PM EST
  12. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  13. Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences

    GuruFocus | Dec. 13, 2015 | 01:35AM EST
  14. Apple Gets Bullish Call; GoPro Downgraded, Adobe Hiked

    IBD | Dec. 11, 2015 | 08:51AM EST
  15. Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals

    GuruFocus | Dec. 10, 2015 | 10:35AM EST
  16. Alexion Pharmaceuticals

    IBD | Dec. 8, 2015 | 18:53PM EST
  17. Alexion Wins Third Drug Approval; Stock Rises

    IBD | Dec. 8, 2015 | 14:18PM EST
  18. ADDING MULTIMEDIA FDA Approves Kanuma™ (sebelipase alfa) for the Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D)

    Benzinga | Dec. 8, 2015 | 12:55PM EST
  19. Alexion Pharmaceuticals Loses Position in Swensen's Portfolio

    GuruFocus | Dec. 3, 2015 | 13:27PM EST
  20. EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks

    Benzinga | Nov. 25, 2015 | 09:53AM EST
  21. David Swensen's Transactions Show Diversity of Portfolio

    GuruFocus | Nov. 19, 2015 | 10:28AM EST
  22. Jim Simons' Largest Adds of the 3rd Quarter

    GuruFocus | Nov. 13, 2015 | 11:59AM EST
  23. Baron Funds Comments on Alexion Pharmaceuticals Inc.

    GuruFocus | Nov. 10, 2015 | 12:23PM EST
  24. Alexion Announces Study Presented at ASN 2015 Supports Effectiveness of Soliris in Preventing TMA Events in Patients with aHUS

    Benzinga | Nov. 7, 2015 | 20:00PM EST
  25. Alexion gets Synageva boost

    IBD | Oct. 29, 2015 | 18:51PM EST
  26. Earnings Scheduled For October 29, 2015

    Benzinga | Oct. 29, 2015 | 04:31AM EST
  27. Biotech ETFs: Buy, Buy, Buy?

    Benzinga | Oct. 27, 2015 | 07:19AM EST
  28. Friday's After Hours Movers: Alexion Pharma Resumes Trading Following Halt

    Benzinga | Oct. 23, 2015 | 16:48PM EST
  29. Alexion Release Confirms FDA Approves Strensiq™ (asfotase alfa) for Treatment of Patients with Perinatal-, Infantile- and Juvenile-Onset Hypophosphatasia (HPP)

    Benzinga | Oct. 23, 2015 | 15:50PM EST
  30. Cowen: In Biotech Earnings We Trust

    Benzinga | Oct. 19, 2015 | 10:02AM EST
  31. Stocks Climb As Biotechs Rebound; Tesla Slips On Shift Into Neutral

    IBD | Oct. 7, 2015 | 14:43PM EST
  32. Stocks Remain Near Session Highs; Apple Goes Positive On Target News

    IBD | Oct. 2, 2015 | 15:07PM EST
  33. Facebook, Netflix Top Goldman Sachs' 2016 Growth List

    IBD | Oct. 2, 2015 | 14:38PM EST
  34. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD | Oct. 2, 2015 | 12:42PM EST
  35. Benzinga's Top Upgrades

    Benzinga | Oct. 2, 2015 | 09:01AM EST
  36. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD | Oct. 2, 2015 | 08:48AM EST
  37. Morgan Stanley On Big Biotech: Upgrades, Pfizer, Vertex, Alexion, Cuts Gilead, Valeant

    Benzinga | Oct. 2, 2015 | 08:26AM EST
  38. Stocks Rally, Will Gains Hold? Biotechs Try Second Rebound

    IBD | Sep. 30, 2015 | 10:43AM EST
  39. Oppenheimer Is Buying Alexion Pharma On Weakness

    Benzinga | Sep. 24, 2015 | 10:56AM EST
  40. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga | Sep. 14, 2015 | 16:01PM EST
  41. Benzinga's Top Downgrades

    Benzinga | Sep. 14, 2015 | 09:38AM EST
  42. Not So Fast, Alexion Investors

    Benzinga | Sep. 14, 2015 | 09:01AM EST
  43. Frank Sands Shows Bold Side in Second-Quarter Trades

    GuruFocus | Sep. 13, 2015 | 17:25PM EST
  44. Alexion Pharmaceuticals Is Still A Buy, Despite Rx Kanuma's Review-Date Delay

    Benzinga | Sep. 4, 2015 | 15:27PM EST
  45. David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF

    GuruFocus | Aug. 19, 2015 | 18:27PM EST
  46. Baron Funds Comments on Alexion Pharmaceuticals Inc.

    GuruFocus | Aug. 19, 2015 | 12:16PM EST
  47. Yale University Is Bullish On ETFs & Alexion, Sold Twitter Last Quarter

    Benzinga | Aug. 13, 2015 | 16:24PM EST
  48. Dow Delays Death Cross With Big Monday Gain

    Benzinga | Aug. 11, 2015 | 07:43AM EST
  49. The Historical Correlation Between Biotech Stocks And Interest Rates

    Benzinga | Aug. 7, 2015 | 14:39PM EST
  50. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD | Aug. 5, 2015 | 14:58PM EST
Trading Center